BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 9759378)

  • 21. Activation of RhoA and SAPK/JNK signalling pathways by the RhoA-specific exchange factor mNET1.
    Alberts AS; Treisman R
    EMBO J; 1998 Jul; 17(14):4075-85. PubMed ID: 9670022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling.
    Stam JC; Michiels F; van der Kammen RA; Moolenaar WH; Collard JG
    EMBO J; 1998 Jul; 17(14):4066-74. PubMed ID: 9670021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asef is a Cdc42-specific guanine nucleotide exchange factor.
    Gotthardt K; Ahmadian MR
    Biol Chem; 2007 Jan; 388(1):67-71. PubMed ID: 17214551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the first Rho-GEF inhibitor, TRIPalpha, which targets the RhoA-specific GEF domain of Trio.
    Schmidt S; Diriong S; Méry J; Fabbrizio E; Debant A
    FEBS Lett; 2002 Jul; 523(1-3):35-42. PubMed ID: 12123800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skeletal muscle deformity and neuronal disorder in Trio exchange factor-deficient mouse embryos.
    O'Brien SP; Seipel K; Medley QG; Bronson R; Segal R; Streuli M
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12074-8. PubMed ID: 11050238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning and characterization of GEF-H1, a microtubule-associated guanine nucleotide exchange factor for Rac and Rho GTPases.
    Ren Y; Li R; Zheng Y; Busch H
    J Biol Chem; 1998 Dec; 273(52):34954-60. PubMed ID: 9857026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of lamellipodia by Kalirin does not require its guanine nucleotide exchange factor activity.
    Schiller MR; Blangy A; Huang J; Mains RE; Eipper BA
    Exp Cell Res; 2005 Jul; 307(2):402-17. PubMed ID: 15950621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucosylation and ADP ribosylation of rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling.
    Sehr P; Joseph G; Genth H; Just I; Pick E; Aktories K
    Biochemistry; 1998 Apr; 37(15):5296-304. PubMed ID: 9548761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of TRIO-GEFD1 chemical inhibitors using the yeast exchange assay.
    Blangy A; Bouquier N; Gauthier-Rouvière C; Schmidt S; Debant A; Leonetti JP; Fort P
    Biol Cell; 2006 Sep; 98(9):511-22. PubMed ID: 16686599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct functions of Trio GEF domains in axon outgrowth of cerebellar granule neurons.
    Tao T; Sun J; Peng Y; Wang P; Chen X; Zhao W; Li Y; Wei L; Wang W; Zheng Y; Wang Y; Zhang X; Zhu MS
    J Genet Genomics; 2019 Feb; 46(2):87-96. PubMed ID: 30850274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of RhoA GTP hydrolysis by the GTPase-activating proteins p190, p50RhoGAP, Bcr, and 3BP-1.
    Zhang B; Zheng Y
    Biochemistry; 1998 Apr; 37(15):5249-57. PubMed ID: 9548756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
    Boissier P; Huynh-Do U
    Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the guanine nucleotide exchange factor Dbl following ACK1-dependent tyrosine phosphorylation.
    Kato J; Kaziro Y; Satoh T
    Biochem Biophys Res Commun; 2000 Feb; 268(1):141-7. PubMed ID: 10652228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The nucleotide exchange rates of rho and rac small GTP-binding proteins are enhanced to different extents by their regulatory protein Smg GDS.
    Sasaki T; Kato M; Nishiyama T; Takai Y
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1188-93. PubMed ID: 8352776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A local VE-cadherin and Trio-based signaling complex stabilizes endothelial junctions through Rac1.
    Timmerman I; Heemskerk N; Kroon J; Schaefer A; van Rijssel J; Hoogenboezem M; van Unen J; Goedhart J; Gadella TW; Yin T; Wu Y; Huveneers S; van Buul JD
    J Cell Sci; 2015 Aug; 128(16):3041-54. PubMed ID: 26116572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncogenic activity of Tiam1 and Rac1 in NIH3T3 cells.
    van Leeuwen FN; van der Kammen RA; Habets GG; Collard JG
    Oncogene; 1995 Dec; 11(11):2215-21. PubMed ID: 8570171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GEF-mediated GDP/GTP exchange by monomeric GTPases: a regulatory role for Mg2+?
    Pan JY; Wessling-Resnick M
    Bioessays; 1998 Jun; 20(6):516-21. PubMed ID: 9699463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation.
    Zohar M; Teramoto H; Katz BZ; Yamada KM; Gutkind JS
    Oncogene; 1998 Aug; 17(8):991-8. PubMed ID: 9747878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The DH and PH domains of Trio coordinately engage Rho GTPases for their efficient activation.
    Chhatriwala MK; Betts L; Worthylake DK; Sondek J
    J Mol Biol; 2007 May; 368(5):1307-20. PubMed ID: 17391702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The trio guanine nucleotide exchange factor is a RhoA target. Binding of RhoA to the trio immunoglobulin-like domain.
    Medley QG; Serra-Pagès C; Iannotti E; Seipel K; Tang M; O'Brien SP; Streuli M
    J Biol Chem; 2000 Nov; 275(46):36116-23. PubMed ID: 10948190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.